// App-Quantinova.ai

5057 : Imaging response during therapy with radium-223 (Ra-223) for castration-resistant prostate cancer (CRPC) with bone metastases (BM) A multicenter analysis.

Researchers

Presenter

  • Aurelius Gabriel Omlin

Principal Investigators

  • Avivit Peer

  • Hermann Reichegger

  • Avivit Neumann

  • Eli Rosenbaum

  • Marie-Claire Desax

  • Victoria Neiman

  • Peter Meidahl Petersen

  • Joachim Mueller

  • Richard Cathomas

  • Maya Gottfried

  • David Sarid

  • Eli Gez

  • Wilmosh Mermershtain

  • Keren Rouvinov

  • Jann Mortensen

  • Silke Gillessen

  • Daniel Keizman

Medical Centers

  • Kantonsspital St Gallen, St Gallen, Switzerland

  • Copenhagen University Hospital, Copenhagen, Denmark

  • Rambam Health Care Campus, Haifa, Israel

  • Kantonsspital St Gallen, St Gallen, Switzerland

  • Department of Oncology, Rambam Medical Center, Haifa, Israel

  • Department of Nephrology, Rabin Medical Center, Petah-Tikva, Israel

  • Davidoff Center, Rabin Medical Center, Petach-Tikva, Israel

  • Department of Hematology, Rigshospitalet, Copenhagen, Denmark

  • Kantonsspital Chur, Chur, Switzerland

  • Lung Cancer Unit, Meir Medical Center, Kfar Saba, Israel

  • Ichilov Hospital - Sourasky Medical Center, Tel Aviv, Israel

  • Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel

  • Soroka Medical Center, Beersheba, Israel

  • Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark

  • Genitourinary Oncology Service, Division of Oncology, Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel

Locations

  • Switzerland

  • Denmark

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

  • Bone metastases

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Radium-223 Dichloride

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved